Analysts Set Guardant Health, Inc. (NASDAQ:GH) Target Price at $46.75
Shares of Guardant Health, Inc. (NASDAQ:GH – Get Free Report) have been given a consensus recommendation of “Moderate Buy” by the twelve analysts that are currently covering the company, MarketBeat Ratings reports. Two investment analysts have rated the stock with a hold rating and ten have issued a buy rating on the company. The average […]